The global Respiratory Care Devices Market is valued at $23.93 billion in 2024 and is projected to reach a value of $54.38 ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

This season, the recovery period has extended beyond the typical five to seven days, with many individuals experiencing ...

Drying wet clothing indoors in poorly ventilated spaces could increase the amount of mould growing in your home ...

Market OverviewThe Global Oxygen Therapy Equipment Market is valued at USD 3.8 Billion in 2024 and is projected to reach a ...

Toxic air led to more Delhi residents seeking treatment for asthma, chronic obstructive pulmonary disease (COPD) and ...

Indian insurers are considering making New Delhi residents pay 10% to 15% more for new health policies after an extraordinary ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...

To implement such a change, insurers must first submit evidence to Irdai demonstrating a direct correlation between toxic air ...